Results 81 to 90 of about 1,869,033 (226)
Organoprotective effects of serelaxin in patients with severe decompensated heart failure
Serelaxin (recombinant molecule of the human relaxin-2) is an innovative drug for the treatment of acute heart failure. Preclinical and clinical studies demonstrated the ability of serelaxin to relieve the symptoms of heart failure, provide a significant
Z. D. Kobalava +3 more
doaj +1 more source
Spontaneous Chylothorax in a Case of Cardio-Facio-Cutaneous Syndrome
A patient is reported who fulfills the diagnostic criteria for severe cardio-facio-cutaneous syndrome who developed a chylothorax.
CHAN, PEI-CHUN;CHIU, HSIEN-CHING;HWU, WUH-LIANG +1 more
core
Cardio-renal interrelation: modern view
The paper discusses the definition and classification of cardio-renal syndrome (CRS) - a pathological process in heart or kidneys, characterised by acute or chronic dysfunction of one organ which results in acute or chronic failure of the other organ ...
Villewalde S.V. +3 more
core
Abstract The antihypertensive mechanism of sodium–glucose cotransporter 2 (SGLT2) inhibitors has been traditionally attributed to osmotic diuresis. However, emerging evidence reveals multifaceted mechanisms beyond diuresis, including regulation of the renin–angiotensin–aldosterone system, sympathetic nervous system suppression, ion homeostasis ...
Chunxiang Xu +5 more
wiley +1 more source
Menopause and vascular endothelial health: Is it all about the oestrogen?
Abstract Cardiovascular disease (CVD) is a leading cause of mortality in women, and CVD risk is accelerated during the menopause transition. This acceleration has traditionally been attributed to the hallmark decline in oestradiol with menopause. However, the menopause transition is also characterized by changes in other sex hormones that exert effects
Virginia R. Nuckols +4 more
wiley +1 more source
Cardio-renal-metabolic syndrome – an independent clinical picture?
Chronic kidney disease (CKD) and heart diseases (cardiovascular disease, atherosclerotic heart disease, heart failure) and metabolic diseases (metabolic syndrome [MetS], type 2 diabetes [T2DM], hyperuricemia) often occur together.
Ede Kékes
doaj +1 more source
Cardiorenal syndrome (CRS) involves multiple organs. It refers to acute or chronic cardiac or renal dysfunction. Its pathophysiology involves immune inflammation,oxidative damage,anemia,iron metabolism disorders,dyslipidemia,hemodynamic disorders ...
A Rou-na +3 more
doaj
Abstract figure legend Regulatory mechanisms such as alternative splicing, post‐translational modification, membrane trafficking, and protein interactions control channel gating, membrane abundance, and overall activity of PIEZO2. Proper regulation supports PIEZO2‐dependent proprioceptive, somatosensory, nociceptive, pruriceptive and interoceptive ...
Eunice I. Oribamise +2 more
wiley +1 more source
Cardio-renal anemia syndrome and Erythropoietin Stimulating Agents (ESA) [PDF]
120004665359近年の様々な疫学調査や大規模臨床試験により,慢性腎臓病(CKD)が心血管疾患(CVD)の独立した危険因子であることが明らかになった.さらに,CKD のCVD へのリスクとなる間に介在する要因として,貧血が大きな役割を果たしていることが証明されてきた.このようにCKD,CVD,貧血がお互いに悪影響を及ぼし合い,悪循環を形成するという考えをcardio-renal-anemia syndromeと呼ぶようになった.保存期CKD やうっ血性心不全に対する介入は困難が予想される.一方で ...
出口, 雅子 +6 more
core
There is mounting evidence that forward heart failure as manifested by low cardiac output alone does not define the degree of renal dysfunction in cardiorenal syndrome. As a result, the term “congestive renal failure” was coined in 2012 by Ross to depict
Nneoma Agbasi +3 more
core +1 more source

